Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
Archives of Otolaryngology--Head & Neck Surgery|February 1, 1995
Serum immunoglobulins specific for intracellular proteins of squamous cell carcinomaE Calenoff, M A Cheever, M Satam, et al.Cancer Research|September 1, 1990
Monoclonal antibody therapy of murine lymphoma: enhanced efficacy by concurrent administration of interleukin 2 or lymphokine-activated killer cellsK R Schultz, J P Klarnet, D J Peace, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapyK J Liu, G S Chatta, D R Twardzik, et al.Transplantation|March 1, 1982
Nonbacterial nonfungal pneumonia following marrow transplantation in 100 identical twinsF R Applebaum, J D Meyers, A Fefer, et al.Vaccine|March 21, 2001
Vaccination with Her-2/neu DNA or protein subunits protects against growth of a Her-2/neu-expressing murine tumorT M Foy, J Bannink, R A Sutherland, et al.Blood|September 1, 1981
Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twinsF R Appelbaum, A Fefer, M A Cheever, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1984
Interleukin 2 administered in vivo induces the growth of cultured T cells in vivoM A Cheever, P D Greenberg, C Irle, et al.Cancer Immunology, Immunotherapy : CII|July 1, 1997
Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatmentJ I Clark, R K Alpaugh, M von Mehren, et al.Vaccine|April 28, 2005
Development of a CTL vaccine for Her-2/neu using peptide-microspheres and adjuvantsS P Mossman, L S Evans, H Fang, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memoryJ P Klarnet, L A Matis, D E Kern, et al.Pageof 11